Coinfection of chronic hepatitis B and fasciolosis.
Chronic hepatitis B and fasciolosis are associated with the induction of T-cell responses polarized to the Th2 subtype. Interferon-alpha enhances innate immunity as well as Th1 immune response. We present a male patient with chronic hepatitis B and fasciolosis who responded to chronic hepatitis treatment with hepatitis B virus (HBV) vaccine, interferon-alpha-2b and lamivudine.
Demirci
M
M
Dept. of Microbiology and Clinical Microbiology, Süleyman Demirel University, Faculty of Medicine, Hizirbey Mah. 1538 sk. No. 6, TR-32100, Isparta, Turkey. demircidr@hotmail.com
Isler
M
M
Cicioglu Aridogan
B
B
Senol
A
A
Korkmaz
M
M
D000328:Adult; D000818:Animals; D004359:Drug Therapy, Combination; D005211:Fascioliasis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D008111:Liver Function Tests; D008297:Male; D011994:Recombinant Proteins; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D017325:Hepatitis B Vaccines; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine